 |
Chair: Dr. Sabine Hauck, Leukocare AG, Germany |
 |
Vice Chair: Dr. Andrea Hauser, University Hospital Regensburg
|
 |
Prof. Martin Hildebrandt, TU Munich, Germany |
 |
Niina Taylor, Pfizer, Great Britain |
 |
Koen Huygens,
Koen Huygens BVBA, Belgium |
 |
Dr. Hiltrud Horn, Horn Pharmaceutical Consulting, Germany |
 |
Tricia Harbinson,
Pfizer, Great Britain |
 |
Dr. Georg Belke-Louis, Apceth, Germany |
 |
Dr. Hans Henskens, Lonza Netherlands BV |
 |
Dr. Ralf Sanzenbacher,
Paul-Ehrlich-Institute, German Federal Agency for Vaccines and Biomedicines |
 |
Jan-Oliver Karo, Paul-Ehrlich-Institute, German Federal Agency for Vaccines and Biomedicines |